MediWound Ltd. - Common Shares (MDWD)

CUSIP: M68830104

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Shares
Shares outstanding
12,838,938
Total 13F shares
4,541,601
Share change
-1,672,438
Total reported value
$13,490,000
Price per share
$2.97
Number of holders
23
Value change
-$4,902,499
Number of buys
11
Number of sells
4

Security key

M68830104

Report period

Q2 2020

Institutions

23

Top holders

10

Top shareholders of MDWD - MediWound Ltd. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
19%
2,414,434
$3,790,000 31 Mar 2020
13F
Migdal Insurance & Financial Holdings Ltd.
13F
Company
17%
2,126,058
$3,338,000 31 Mar 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.6%
465,276
$730,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
1.7%
219,386
$345,000 31 Mar 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
1.6%
209,604
$329,000 31 Mar 2020
13F
Na Bokf
13F
Individual
1.6%
206,234
$324,000 31 Mar 2020
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1%
130,072
$205,000 31 Mar 2020
13F
Sargent Investment Group, LLC
13F
Company
0.91%
117,400
$184,000 31 Mar 2020
13F
Harel Insurance Investments & Financial Services Ltd.
13F
Company
0.79%
101,381
$159,000 31 Mar 2020
13F
Fortis Advisors, LLC
13F
Company
0.54%
68,711
$108,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
0.34%
43,919
$69,000 31 Mar 2020
13F
OPPENHEIMER & CO INC
13F
Company
0.32%
41,200
$65,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
23,801
$37,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
0.18%
23,318
$37,000 31 Mar 2020
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.09%
11,484
$18,000 31 Mar 2020
13F
UBS Group AG
13F
Company
0.04%
5,500
$9,000 31 Mar 2020
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.03%
3,350
$5,000 31 Mar 2020
13F
Kore Private Wealth LLC
13F
Company
0.02%
2,000
$3,000 31 Mar 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
1,311
$2,000 31 Mar 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
600
$1,000 31 Mar 2020
13F
Elmwood Wealth Management, Inc.
13F
Company
0%
30
$156 31 Mar 2020
13F

Institutional Holders of MediWound Ltd. - Common Shares (MDWD) as of Q2 2020

As of 30 Jun 2020, MediWound Ltd. - Common Shares (MDWD) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,541,601 shares. The largest 10 holders included Migdal Insurance & Financial Holdings Ltd., RENAISSANCE TECHNOLOGIES LLC, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BOKF, NA, ACADIAN ASSET MANAGEMENT LLC, Sargent Investment Group, LLC, Phoenix Holdings Ltd., and OPPENHEIMER & CO INC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
20
Q2 2020 holders
23
Holder diff
3
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .